UofL innovator known for drug discovery inducted into National Academy of Inventors

John Trent, a University of Louisville researcher and innovator known for harnessing the power of thousands of computers to discover drugs that could fight everything from cancer to coronavirus, has been named a Fellow of the National Academy of Inventors.

Fellows are selected for their “spirit of innovation” in university research, helping to generate groundbreaking inventions that have a tangible impact on the quality of life, economic development and the welfare of society.

Trent is the only 2020 fellow from the state of Kentucky and the seventh from the University of Louisville. The 2020 Fellow class of 175 inventors represents 115 research universities and governmental and non-profit research institutes worldwide.

As deputy director of basic and translational research at the UofL Health – Brown Cancer Center, Trent’s Molecular Modeling Facility uses computer predictions to understand and virtually test how drug and disease molecules might interact before real-world testing in the lab.

Trent also runs the UofL partnership with Dataseam, a company that created a grid that uses the processing power of thousands of computers in schools across Kentucky that Trent uses to screen potential drugs and compounds against cancer targets and, most recently, SARS-CoV-2 and COVID 19. The DataseamGrid has the capability to screen millions of potential compounds against molecular targets in only a few days.

The 2020 NAI Fellow class collectively holds more than 4,700 issued U.S. patents.

Please see the full article by Baylee Pullam here.